Share this
Tracking Student Athletes’ Brain Injuries Using Microsampling Devices
by Neoteryx Microsampling on December 15,2022
December 2022 — Neoteryx, a brand of Trajan Scientific and Medical that provides remote specimen collection and microsampling devices, recently launched a Research Support Program that enables researchers to test the feasibility of microsampling in early-phase studies ranging from novel biomarkers to rare diseases.
The first recipient of this support program is a research group in the Queensland Brain Institute (QBI) at The University of Queensland, Australia. The group is led by Associate Professor Fatima Nasrallah, PhD, a leading neuroscientist in the field of concussion and brain injury with a background in magnetic resonance and interdisciplinary brain research.
Nasrallah's research group will use donated remote specimen collection devices from Trajan Scientific and Medical to study head injuries and recovery times in student athletes, investigating a reliable method for concussion diagnosis.
Hundreds of Mitra® microsampling devices, which precisely collect drops of blood from a finger-prick, were donated by Trajan as an “in kind” gift, to help Associate Professor Nasrallah and her team launch a pilot study that includes collecting blood samples from student athletes who play rugby and basketball at nine private schools in Queensland, Australia and a control group of swimmers.
The portable, user-friendly Mitra microsampling devices should make it easier for both researchers and athletes to collect blood samples in different settings and at different time points.
“It is estimated that athletes around the globe sustain 42 million concussions each year, yet the diagnosis of concussion and its recovery is not straightforward, complicating its management,” said Fatima Nasrallah, PhD, Associate Professor, QBI, The University of Queensland. “As part of our pilot study, we will use Mitra devices to collect blood microsamples from student rugby players, basketball players and swimmers at local schools. By combining the data gathered from magnetic resonance imaging, cognitive testing and the microsamples, we aim to identify a biomarker that helps us monitor brain injuries and the healing process longitudinally. Data from the blood samples will help QBI track injury severity and recovery times.”
After initial blood sampling by the researchers, student athletes will learn to use the Mitra devices at home to collect blood samples at different time points. The World Rugby Association is collaborating with QBI on this study.
It is hoped that the findings of this study will increase understanding of TBI and may help sports agencies better determine when it is safe for athletes to return to the playing field. Ultimately, this knowledge could lead to a new diagnostic tool for concussions.
About Neoteryx
Neoteryx is a brand of Trajan Scientific and Medical, providing scientifically precise remote specimen collection and microsampling technologies. To support Trajan’s vision of enabling science that benefits people and improves wellbeing, the Neoteryx team innovates and develops quantitative microsampling technologies that are easy to use and amenable to manual and automated analysis in the lab.
Neoteryx microsampling technologies ease workflows and enable decentralized research and healthcare models. The product portfolio includes the Mitra® device based on VAMS® technology and the hemaPEN® that advances both capillary and DBS technologies, with more microsampling products in the pipeline. For information about microsampling, visit www.neoteryx.com. For information about Trajan’s other brands and services, visit www.trajanscimed.com.
Share this
- Microsampling (41)
- Mitra® Device (34)
- Industry News, Microsampling News (33)
- Company Press Release, Product Press Release (21)
- Research, Remote Research (18)
- Infectious Disease, Vaccines, COVID-19 (15)
- Clinical Trials, Clinical Research (14)
- Blood Microsampling, Serology (10)
- Biomonitoring, Health, Wellness (9)
- Decentralized Clinical Trial (DCT) (8)
- Omics, Multi-Omics (7)
- Venipuncture Alternative (6)
- Specimen Collection (3)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (3)
- Pharmaceuticals, Drug Development (2)
- Skin Microsampling, Microbiopsy (2)
- Therapeutic Drug Monitoring, TDM (2)
- Antibodies, MAbs (1)
- Environmental Toxins, Exposures (1)
- Preclinical Research, Animal Studies (1)
- hemaPEN® Device (1)
- September 2024 (1)
- August 2024 (1)
- May 2024 (2)
- January 2024 (1)
- December 2023 (2)
- November 2023 (3)
- October 2023 (2)
- September 2023 (1)
- August 2023 (3)
- July 2023 (3)
- June 2023 (1)
- May 2023 (2)
- April 2023 (1)
- March 2023 (2)
- February 2023 (1)
- January 2023 (2)
- December 2022 (1)
- November 2022 (1)
- October 2022 (2)
- August 2022 (1)
- April 2022 (1)
- February 2022 (1)
- January 2022 (1)
- December 2021 (1)
- November 2021 (1)
- October 2021 (2)
- September 2021 (1)
- August 2021 (2)
- July 2021 (2)
- June 2021 (2)
- April 2021 (1)
- March 2021 (2)
- February 2021 (1)
- January 2021 (1)
- December 2020 (1)
- November 2020 (1)
- October 2020 (1)
- September 2020 (2)
- August 2020 (3)
- July 2020 (3)
- June 2020 (2)
- May 2020 (1)
- April 2020 (3)
- October 2019 (1)
- March 2019 (1)
- January 2019 (1)
- November 2018 (1)
- August 2018 (1)
- July 2018 (1)
- June 2017 (1)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- May 2016 (1)
- December 2015 (1)
- October 2015 (1)
- August 2015 (1)
- August 2014 (1)
- July 2014 (1)
Comments (2)